STOCK TITAN

[SCHEDULE 13G] Pyxis Oncology, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/30/2025
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/30/2025
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:06/30/2025
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of June 30, 2025, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

Pyxis Oncology, Inc.

NASDAQ:PYXS

PYXS Rankings

PYXS Latest News

PYXS Latest SEC Filings

PYXS Stock Data

66.28M
47.44M
23.41%
40.4%
7.72%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON